Discover
ERNA
Ernexa Therapeutics Inc.
6.70
2 x 5.25
2 x 8.44
bid
ask
+
0.05
0.82%
2 @ 04:00 PM
6.72 +0.02 (0.24%)
| Ytd | -77.65% | |
| 1y | -85.27% |
6.50
day range
7.28
3.18
52 week range
71.50
| Open | 6.62 | Prev Close | 6.65 | Low | 6.50 | High | 7.28 | Mkt Cap | 7.82M |
| Vol | 96.88K | Avg Vol | 1.65M | EPS | 1214.25 | P/E | 0.01 | Forward P/E | -0.03 |
| Beta | 7.77 | Short Ratio | 1.07 | Inst. Own | 11.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 7.62 | 200-d Avg | 19.79 | 1yr Est | 3.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | 0 | -4.92 | N/A | N/A |
| 2024-08-13 | 2024-06 | 0 | -1.02 | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | -1.23 | N/A | N/A |
| 2024-03-14 | 2023-12 | 0 | -1.14 | N/A | N/A |
| 2023-11-13 | 2023-09 | 0 | -1.03 | N/A | N/A |
| 2023-08-11 | 2023-06 | 0 | -0.85 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-10-28 | CHERINGTON CHARLES | Beneficial Owner of more than 10% of a Class of Security | 16.63M | Conversion of Exercise of derivative security |
| 2024-06-20 | GURROLA SANDRA M | Officer | 1.19K | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Corient Private Wealth LLC | 262.86K | 64.51K | 0.51% |
| 2024-09-29 | Cypress Point Wealth Management, LLC | 94.38K | 23.16K | 0.18% |
| 2024-09-29 | UBS Group AG | 83.62K | 20.52K | 0.16% |
| 2024-09-29 | Naviter Wealth, LLC | 78.80K | 19.34K | 0.15% |
| 2024-09-29 | Sippican Capital Advisors | 68.50K | 16.81K | 0.13% |
| 2024-09-29 | Two Sigma Securities, LLC | 32.86K | 8.06K | 0.06% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 26.10K | 6.40K | 0.05% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 13.10K | 3.21K | 0.03% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 3.13K | 767.00 | 0.01% |
| 2024-08-30 | Guggenheim Active Allocation Fund | 8.00 | 1.00 | 0.00% |
| 2024-10-30 | Fidelity Total Market Index Fund | 2.05K | 502.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 25 | 2026-05-04 |
| 1 : 15 | 2025-06-12 |
| 1 : 20 | 2022-10-17 |
| 1 : 2 | 2021-03-26 |
| 1 : 50 | 2016-06-17 |